Ignacio Garcia-Alonso

Prof. Ignacio Garcia-Alonso

University of The Basque Country
orcid

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 June 2022 in Cancers
Verified
Journal Article
Open access
PDF file
Borja Herrero de la ParteBorja Herrero de la Parte
Borja Herrero de la Parte
IRIrati Rodrigo
Irati Rodrigo
JGJon Gutiérrez-Basoa
Jon Gutiérrez-Basoa
SCSira Iturrizaga Correcher
Sira Iturrizaga Correcher
CMCarmen Mar Medina
Carmen Mar Medina
Ignacio Garcia-AlonsoIgnacio Garcia-Alonso
Ignacio Garcia-Alonso
Background: Lately, major advances in crucial aspects of magnetic hyperthermia (MH) therapy have been made (nanoparticle synthesis, biosafety, etc.). However, there is one key point still lacking improvement: the magnetic field-frequency product (H × f = 4.85 × 108 Am−1s−1) proposed by Atkinson–Brezovich as a limit for MH therapies. Herein, we analyze both local and systemic physiological effects of overpassing this limit. Methods: Different combinations of field frequency and intensity exceeding the Atkinson–Brezovich limit (591–920 kHz, and 10.3–18 kA/m) have been applied for 21 min to WAG/RijHsd male rats, randomly distributed to groups of 12 animals; half of them were sacrificed after 12 h, and the others 10 days later. Biochemical serum analyses were performed to assess the general, hepatic, renal and/or pancreatic function. Results: MH raised liver temperature to 42.8 ± 0.4 °C. Although in five of the groups the exposure was relatively well tolerated, in the two of highest frequency (928 kHz) and intensity (18 kA/m), more than 50% of the animals died. A striking elevation in liver and systemic markers was observed after 12 h in the surviving animals, independently of the frequency and intensity used. Ten days later, liver markers were almost recovered in all of the animals. However, in those groups exposed to 591 kHz and 16 kA/m, and 700 kHz and 13.7 kA/m systemic markers remained altered. Conclusions: Exceeding the Atkinson–Brezovich limit up to 9.59 × 109 Am−1s−1 seems to be safe, though further research is needed to understand the impact of intensity and/or frequency on physiological conditions following MH.

6 May 2018 in Nanomaterials
Verified
Journal Article
Open access
PDF file
SSSpiridon V. Spirou
Spiridon V. Spirou
Sofia LimaSofia Lima
Sofia Lima
PGPenelope Greece
Penelope Greece
SDSanja Vranjes Djuric
Sanja Vranjes Djuric
EEEleni Κ. Efthimiadou
Eleni Κ. Efthimiadou
Oliviero L. GobboOliviero L. Gobbo
Oliviero L. Gobbo
Magnetic nanoparticle (MNP)-mediated hyperthermia (MH) coupled with radiation therapy (RT) is a novel approach that has the potential to overcome various practical difficulties encountered in cancer treatment. In this work, we present recommendations for the in vitro and in vivo testing and application of the two treatment techniques. These recommendations were developed by the members of Working Group 3 of COST Action TD 1402: Multifunctional Nanoparticles for Magnetic Hyperthermia and Indirect Radiation Therapy (“Radiomag”). The purpose of the recommendations is not to provide definitive answers and directions but, rather, to outline those tests and considerations that a researcher must address in order to perform in vitro and in vivo studies. The recommendations are divided into 5 parts: (a) in vitro evaluation of MNPs; (b) in vitro evaluation of MNP-cell interactions; (c) in vivo evaluation of the MNPs; (d) MH combined with RT; and (e) pharmacokinetic studies of MNPs. Synthesis and characterization of the MNPs, as well as RT protocols, are beyond the scope of this work.

28 October 2016 in Beilstein Journal of Nanotechnology
Verified
Journal Article
Open access
PDF file
OAOihane K. Arriortua
Oihane K. Arriortua
EGEneko Garaio
Eneko Garaio
Borja Herrero de la ParteBorja Herrero de la Parte
Borja Herrero de la Parte
MIMaite Insausti
Maite Insausti
LLLuis Lezama
Luis Lezama
JEJosé Javier Echevarria-Uraga
José Javier Echevarria-Uraga
This work reports important advances in the study of magnetic nanoparticles (MNPs) related to their application in different research fields such as magnetic hyperthermia. Nanotherapy based on targeted nanoparticles could become an attractive alternative to conventional oncologic treatments as it allows a local heating in tumoral surroundings without damage to healthy tissue. RGD-peptide-conjugated MNPs have been designed to specifically target αVβ3 receptor-expressing cancer cells, being bound the RGD peptides by “click chemistry” due to its selectivity and applicability. The thermal decomposition of iron metallo-organic precursors yield homogeneous Fe3O4 nanoparticles that have been properly functionalized with RGD peptides, and the preparation of magnetic fluids has been achieved. The nanoparticles were characterized by transmission electron microscopy (TEM), vibrating sample magnetometry (VSM), electron magnetic resonance (EMR) spectroscopy and magnetic hyperthermia. The nanoparticles present superparamagnetic behavior with very high magnetization values, which yield hyperthermia values above 500 W/g for magnetic fluids. These fluids have been administrated to rats, but instead of injecting MNP fluid directly into liver tumors, intravascular administration of MNPs in animals with induced colorectal tumors has been performed. Afterwards the animals were exposed to an alternating magnetic field in order to achieve hyperthermia. The evolution of an in vivo model has been described, resulting in a significant reduction in tumor viability.

8 July 2015 in Arthroscopy
Verified
Journal Article
Closed access
ACAdrián Cuéllar
Adrián Cuéllar
RCRicardo Cuéllar
Ricardo Cuéllar
ACAsier Cuéllar
Asier Cuéllar
Ignacio Garcia-AlonsoIgnacio Garcia-Alonso
Ignacio Garcia-Alonso
MRMiguel Angel Ruiz‐Ibán
Miguel Angel Ruiz‐Ibán

27 May 2021 in Antioxidants
Verified
Journal Article
Open access
PDF file
GGGaizka Gutiérrez-Sánchez
Gaizka Gutiérrez-Sánchez
Ignacio Garcia-AlonsoIgnacio Garcia-Alonso
Ignacio Garcia-Alonso
JMJorge Gutiérrez Sáenz de Santa María
Jorge Gutiérrez Sáenz de Santa María
Ana Alonso-VaronaAna Alonso-Varona
Ana Alonso-Varona
Borja Herrero de la ParteBorja Herrero de la Parte
Borja Herrero de la Parte
Intestinal ischemia-reperfusion injury (i-IRI) is a rare disorder with a high mortality rate, resulting from the loss of blood flow to an intestinal segment. Most of the damage is triggered by the restoration of flow and the arrival of cytokines and reactive oxygen species (ROS), among others. Inactivation of these molecules before tissue reperfusion could reduce intestinal damage. The aim of this work was to analyze the preventive effect of allopurinol and nitroindazole on intestinal mucosal damage after i-IRI. Wag/RijHsd rats were subjected to i-IRI by clamping the superior mesenteric artery (for 1 or 2 h) followed by a 30 min period of reperfusion. Histopathological intestinal damage (HID) was assessed by microscopic examination of histological sections obtained from injured intestine. HID was increased by almost 20% by doubling the ischemia time (from 1 to 2 h). Nitroindazole reduced HID in both the 1 and 2 h period of ischemia by approximately 30% and 60%, respectively (p < 0.001). Our preliminary results demonstrate that nitroindazole has a preventive/protective effect against tissue damage in the early stages of i-IRI. However, to better understand the molecular mechanisms underlying this phenomenon, further studies are needed.

8 September 2021 in Biomedicines
Verified
Journal Article
Open access
PDF file
Borja Herrero de la ParteBorja Herrero de la Parte
Borja Herrero de la Parte
MRMikel Rodeño-Casado
Mikel Rodeño-Casado
SCSira Iturrizaga Correcher
Sira Iturrizaga Correcher
CMCarmen Mar Medina
Carmen Mar Medina
Ignacio Garcia-AlonsoIgnacio Garcia-Alonso
Ignacio Garcia-Alonso
Background: New therapeutic approaches are an essential need for patients suffering from colorectal cancer liver metastases. Curcumin, a well-known plant-derived polyphenol, has been shown to play a role in the modulation of multiple signaling pathways involved in the development and progression of certain cancer cells in vitro. This study aims to assess the anti-tumor effect of curcumin on CC531 colorectal cancer cells, both in vitro and in vivo. Methods: On CC531 cultures, the cell viability and cell migration capacity were analyzed (wound healing test) 24, 48, and 72 h after treatment with curcumin (15, 20, 25, or 30 µM). Additionally, in WAG/RijHsd tumor-bearing rats, the total and individual liver lobe tumor volume was quantified in untreated and curcumin-treated animals (200 mg/kg/day, oral). Furthermore, serum enzyme measurements (GOT, GPT, glucose, bilirubin, etc.) were carried out to assess the possible effects on the liver function. Results: In vitro studies showed curcumin’s greatest effects 48h after application, when all of the tested doses reduced cell proliferation by more than 30%. At 72 h, the highest doses of curcumin (25 and 30 µM) reduced cell viability to less than 50%. The wound healing test also showed that curcumin inhibits migration capacity. In vivo, curcumin slowed down the tumor volume of liver implants by 5.6-fold (7.98 ± 1.45 vs. 1.41 ± 1.33; p > 0.0001). Conclusions: Curcumin has shown an anti-tumor effect against liver implants from colorectal cancer, both in vitro and in vivo, in this experimental model.